Retrospective Chart Review of Subcutaneous IgG Use in Infants

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Primary Immune Deficiency
Interventions
BIOLOGICAL

Subcutaneous IgG (SCIG)

Administered according to normal clinical practice

Trial Locations (5)

33612

University of South Florida, Tampa

38105

St. Judes Children's Research Hospital, Memphis

44106

University Hospitals Case Medical Center, Cleveland

55446

Midwest Immunology Clinic, Plymouth

90027

Children's Hospital of Los Angeles, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY